Clinical Trials Sponsored by California Cancer Consortium

Total 1771 results

California Cancer Consortium
National Cancer Institute (NCI)

Terminated

Irinotecan in Treating Patients With Colorectal Cancer

Colorectal Cancer

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Lymphoma | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm

United States
California Cancer Consortium
National Cancer Institute (NCI)

Terminated

Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition

United States
California Cancer Consortium
National Cancer Institute (NCI)

Terminated

Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer

Gastric Cancer

United States
California Cancer Consortium
National Cancer Institute (NCI)

Completed

Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
University of California, San Francisco
University of California Pancreatic Cancer Consortium (UCPCC)

Recruiting

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms (PanNEN)

Pancreatic Neuroendocrine Neoplasm

United States
Prostate Cancer Clinical Trials Consortium

Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN) (IRONMAN)

Prostate Cancer

United States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
Southern China Urology Cancer Consortium

Unknown

Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients

Carcinoma, Renal Cell | Self Efficacy | Adverse Drug Event

China
University of California, San Francisco
Dana-Farber Cancer Institute; Translational Breast Cancer Research Consortium

Completed

A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer

Metastatic Breast Cancer | Hormone Receptor Positive

United States
M.D. Anderson Cancer Center
MDS Clinical Research Consortium

Completed

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Leukemia

United States
German Cancer Research Center
German Consortium for Translational Cancer Research

Recruiting

Molecularly Aided Stratification for Tumor Eradication Research (NCT-MASTER)

Rare Cancers | Multiomics

Germany
German Cancer Research Center
German Consortium for Translational Cancer Research

Completed

Afatinib in Advanced NRG1-Rearranged Malignancies

Metastatic and Locally Advanced NRG1-rearranged Malignancies

Germany
AIDS Malignancy Consortium
National Cancer Institute (NCI); California Institute for Regenerative Medicine...

Active, not recruiting

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

HIV Infection | Plasmablastic Lymphoma | Recurrent Adult Hodgkin Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Stage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Stage III Follicular... and other conditions

United States
University of California, San Francisco
Tau Consortium; CBD Solutions

Completed

Safety Study of TPI-287 to Treat CBS and PSP (TPI-287-4RT)

Progressive Supranuclear Palsy (PSP) | Corticobasal Degeneration (CBD) | Corticobasal Syndrome (CBS) | Primary Four Repeat Tauopathies (4RT)

United States
Pfizer
Academic GI Cancer Consortium (AGICC)

Terminated

Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies

Metastatic Cancer Pancreas

United States
Attenuon
Prostate Cancer Clinical Trials Consortium

Unknown

Study of ATN-224 in Patients With Prostate Cancer

Prostate Cancer

United States
Lung Cancer Mutation Consortium
Lung Cancer Research Foundation

Recruiting

Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers

NSCLC

United States
Memorial Sloan Kettering Cancer Center
Pediatric Brain Tumor Consortium

Terminated

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

Fanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML)

United States
Fred Hutchinson Cancer Research Center/University...

Withdrawn

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute
Cancer Nutrition Consortium Inc.

Not yet recruiting

Development and Testing of Nutritional Algorithms (NACHO)

Quality of Life | Nutrition Poor | Nutritional Deficiency

United States
Stanford University
University of California, Irvine; Cornell University; Pritzker Consortium

Completed

Identifying Biological Markers for Severe Depression

Major Depressive Disorder

United States
University of California, San Francisco
North American Gamma Knife Consortium

Withdrawn

Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases (NAGKC 12-01)

Brain Metastases

United States
Major Extremity Trauma Research Consortium
University of California, San Francisco

Completed

Prosthetic Fit Assessment in Transtibial Amputees Secondary to Trauma (ProFit)

Traumatic Amputation of Lower Extremity

United States
University of California, San Francisco
North American Gamma Knife Consortium

Terminated

A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)

Brain Metastases

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Not yet recruiting

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

Kaposi Sarcoma | HIV-1-infection | AIDS-related Kaposi Sarcoma
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Not yet recruiting

Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

HIV Infection | Human Papillomavirus Infection | Human Papillomavirus-Related Carcinoma

United States, India
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

HIV Infection | Anal Cancer | Human Papilloma Virus Infection

United States, Puerto Rico
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Withdrawn

Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma

Lymphoma
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Sarcoma

United States
University of California, San Francisco
National Cancer Institute (NCI); Celgene Corporation; Westat; African Esophageal...

Recruiting

Treatment Outcomes of Esophageal Cancer

Esophageal Cancer

Tanzania, Kenya, Malawi
AIDS Malignancy Consortium
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Not yet recruiting

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

HIV Infection | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent... and other conditions
Baylor Breast Care Center
GlaxoSmithKline; Translational Breast Cancer Research Consortium

Active, not recruiting

Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy (HELEX)

Breast Cancer

United States
OncoC4, Inc.
Prostate Cancer Clinical Trials Consortium

Recruiting

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC (PRESERVE-006)

Metastatic Castration-resistant Prostate Cancer

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Recruiting

Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa

HPV | Ocular Surface Squamous Neoplasia

Uganda
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Recruiting

Trial of Ixazomib for Kaposi Sarcoma

Kaposi Sarcoma | Skin

United States
Sherif Farag

Withdrawn

Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia

Aml | AML, Adult
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

Lymphoma

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Lymphoma

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Withdrawn

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Anaplastic Large Cell Lymphoma | AIDS-related Lymphoma | Adult Non-Hodgkin's Lymphoma
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Not yet recruiting

A Study of Propranolol to Treat Kaposi Sarcoma

Kaposi Sarcoma

Uganda, Argentina, Kenya, Mexico, Malawi, Zimbabwe, Brazil, South Africa
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

HIV Infection | Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Lymphoma | Multicentric Castleman Disease | Plasmablastic Lymphoma | Kaposi Sarcoma | Recurrent Lymphoma | Anal Carcinoma | Recurrent Kaposi Sarcoma | Recurrent Plasmablastic Lymphoma | Transplant-Related Kaposi Sarcoma

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Recruiting

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

HIV Infections | Cancer | HPV-Related Malignancy | Anal Cancer | HIV-Associated Malignant Neoplasm | AIDS Related Lymphoma | AIDS-related Kaposi Sarcoma | AIDS-Related Malignancy

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Recruiting

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

HIV Infection | Tobacco-Related Carcinoma

United States
David VanderWeele

Terminated

Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer (ADDItion)

Castrate Resistant Prostate Cancer

United States
Indiana University
Translational Breast Cancer Research Consortium

Completed

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma

Lymphoma

United States
AIDS Malignancy Consortium
National Cancer Institute (NCI)

Completed

Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia

Precancerous Condition | Anal Cancer

United States

Clinical Trials Sponsored by California Cancer Consortium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations